Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE)
dc.contributor.author | O’donnell M.J. | |
dc.contributor.author | McQueen M. | |
dc.contributor.author | Sniderman A. | |
dc.contributor.author | Pare G. | |
dc.contributor.author | Wang X. | |
dc.contributor.author | Hankey G.J. | |
dc.contributor.author | Rangarajan S. | |
dc.contributor.author | Chin S.L. | |
dc.contributor.author | Rao-Melacini P. | |
dc.contributor.author | Ferguson J. | |
dc.contributor.author | Xavier D. | |
dc.contributor.author | Lisheng L. | |
dc.contributor.author | Zhang H. | |
dc.contributor.author | Pais P. | |
dc.contributor.author | Lopez-Jaramillo P. | |
dc.contributor.author | Damasceno A. | |
dc.contributor.author | Langhorne P. | |
dc.contributor.author | Rosengren A. | |
dc.contributor.author | Dans A.L. | |
dc.contributor.author | Elsayed A. | |
dc.contributor.author | Avezum A. | |
dc.contributor.author | Mondo C. | |
dc.contributor.author | Judge C. | |
dc.contributor.author | Diener H.C. | |
dc.contributor.author | Ryglewicz D. | |
dc.contributor.author | Czlonkowska A. | |
dc.contributor.author | Pogosova N. | |
dc.contributor.author | Weimar C. | |
dc.contributor.author | Iqbal R. | |
dc.contributor.author | Diaz R. | |
dc.contributor.author | Yusoff K. | |
dc.contributor.author | Yusufali A. | |
dc.contributor.author | Oguz A. | |
dc.contributor.author | Penaherrera E. | |
dc.contributor.author | Lanas F. | |
dc.contributor.author | Ogah O.S. | |
dc.contributor.author | Ogunniyi A. | |
dc.contributor.author | Iversen H.K. | |
dc.contributor.author | Malaga G. | |
dc.contributor.author | Rumboldt Z. | |
dc.contributor.author | Oveisgharan S. | |
dc.contributor.author | Hussain F.A. | |
dc.contributor.author | Nilanont Y. | |
dc.contributor.author | Yusuf S. | |
dc.contributor.other | Mahidol University | |
dc.date.accessioned | 2023-06-20T05:30:09Z | |
dc.date.available | 2023-06-20T05:30:09Z | |
dc.date.issued | 2022-06-01 | |
dc.description.abstract | Background and Purpose The association of dyslipidemia with stroke has been inconsistent, which may be due to differing associations within etiological stroke subtypes. We sought to determine the association of lipoproteins and apolipoproteins within stroke subtypes. Methods Standardized incident case-control STROKE study in 32 countries. Cases were patients with acute hospitalized first stroke, and matched by age, sex and site to controls. Concentrations of total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein A1 (apoA1), and apoB were measured. Non-HDL-C was calculated. We estimated multivariable odds ratio (OR) and population attributable risk percentage (PAR%). Outcome measures were all stroke, ischemic stroke (and subtypes), and intracerebral hemorrhage (ICH). Results Our analysis included 11,898 matched case-control pairs; 77.3% with ischemic stroke and 22.7% with ICH. Increasing apoB (OR, 1.10; 95% confidence interval [CI], 1.06 to 1.14 per standard deviation [SD]) and LDL-C (OR, 1.06; 95% CI, 1.02 to 1.10 per SD) were associated with an increase in risk of ischemic stroke, but a reduced risk of ICH. Increased apoB was significantly associated with large vessel stroke (PAR 13.4%; 95% CI, 5.6 to 28.4) and stroke of undetermined cause. Higher HDL-C (OR, 0.75; 95% CI, 0.72 to 0.78 per SD) and apoA1 (OR, 0.63; 95% CI, 0.61 to 0.66 per SD) were associated with ischemic stroke (and subtypes). While increasing HDL-C was associated with an increased risk of ICH (OR, 1.20; 95% CI, 1.14 to 1.27 per SD), apoA1 was associated with a reduced risk (OR, 0.80; 95% CI, 0.75 to 0.85 per SD). ApoB/A1 (OR, 1.38; 95% CI, 1.32 to 1.44 per SD) had a stronger magnitude of association than the ratio of LDL-C/HDL-C (OR, 1.26; 95% CI, 1.21 to 1.31 per SD) with ischemic stroke (P<0.0001). Conclusions The pattern and magnitude of association of lipoproteins and apolipoproteins with stroke varies by etiological stroke subtype. While the directions of association for LDL, HDL, and apoB were opposing for ischemic stroke and ICH, apoA1 was associated with a reduction in both ischemic stroke and ICH. The ratio of apoB/A1 was the best lipid predictor of ischemic stroke risk. | |
dc.identifier.citation | Journal of Stroke Vol.24 No.2 (2022) , 224-235 | |
dc.identifier.doi | 10.5853/jos.2021.02152 | |
dc.identifier.eissn | 22876405 | |
dc.identifier.issn | 22876391 | |
dc.identifier.scopus | 2-s2.0-85131863063 | |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/87296 | |
dc.rights.holder | SCOPUS | |
dc.subject | Medicine | |
dc.title | Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE) | |
dc.type | Article | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85131863063&origin=inward | |
oaire.citation.endPage | 235 | |
oaire.citation.issue | 2 | |
oaire.citation.startPage | 224 | |
oaire.citation.title | Journal of Stroke | |
oaire.citation.volume | 24 | |
oairecerif.author.affiliation | Siriraj Hospital | |
oairecerif.author.affiliation | Dubai Health Authority | |
oairecerif.author.affiliation | Fundación Oftalmológica de Santander | |
oairecerif.author.affiliation | National Medical Research Center for Therapy and Preventive Medicine | |
oairecerif.author.affiliation | Istanbul Medeniyet University | |
oairecerif.author.affiliation | UCSI University | |
oairecerif.author.affiliation | Estudios Clínicos Latinoamérica, Argentina | |
oairecerif.author.affiliation | University of Western Australia, School of Medicine and Pharmacology | |
oairecerif.author.affiliation | Military Institute of Aviation Medicine | |
oairecerif.author.affiliation | School of Medicine, University of Split | |
oairecerif.author.affiliation | Universidad de la Frontera, Facultad de Medicina | |
oairecerif.author.affiliation | Universidade Eduardo Mondlane | |
oairecerif.author.affiliation | Institute of Psychiatry and Neurology, Warszawa | |
oairecerif.author.affiliation | Hospital Luis Vernaza | |
oairecerif.author.affiliation | University of the Philippines College of Medicine | |
oairecerif.author.affiliation | Universidad Peruana Cayetano Heredia | |
oairecerif.author.affiliation | The Aga Khan University Hospital | |
oairecerif.author.affiliation | Sahlgrenska Universitetssjukhuset | |
oairecerif.author.affiliation | Københavns Universitet | |
oairecerif.author.affiliation | Hospital Alemao Oswaldo Cruz | |
oairecerif.author.affiliation | University College Hospital, Ibadan | |
oairecerif.author.affiliation | Universität Duisburg-Essen | |
oairecerif.author.affiliation | King Saud University | |
oairecerif.author.affiliation | Rush Alzheimer’s Disease Center | |
oairecerif.author.affiliation | University of Galway | |
oairecerif.author.affiliation | Hamilton Health Sciences | |
oairecerif.author.affiliation | Centre Universitaire de Santé McGill | |
oairecerif.author.affiliation | St. John's Medical College | |
oairecerif.author.affiliation | University of Glasgow | |
oairecerif.author.affiliation | Kiruddu National Referral Hospital | |
oairecerif.author.affiliation | National Center for Cardiovascular Diseases | |
oairecerif.author.affiliation | Alshaab Teaching Hospital | |
oairecerif.author.affiliation | Beijing Hypertension League Institute |